Mastodon

Polyminerol® (Solution) Instructions for Use

Marketing Authorization Holder

Lavena, AD (Bulgaria)

ATC Code

A01AD11 (Other drugs)

Dosage Form

Bottle OTC Icon Polyminerol® Solution for topical use: bottle 100 ml

Dosage Form, Packaging, and Composition

Solution for topical use opalescent, yellow in color, with a faint thymol-menthol odor.

100 ml
Mother liquor of Pomorie Lake 128.416 g

Excipients: sodium saccharin, ethanol, menthol, thymol.

100 ml – dark glass bottles (1) – cardboard boxes.

Clinical-Pharmacological Group

Drug used for periodontal diseases and gingivitis

Pharmacotherapeutic Group

Topical anti-inflammatory agent

Pharmacological Action

Polyminerol® is a combined preparation of natural origin for topical use in dentistry. The action of the drug is due to the properties of the components that make up the Pomorie Lake lye (macro- and microelements, their salts, colloidal substances).

The drug has a local anti-inflammatory effect, reduces the permeability of blood vessels, stimulates phagocytosis, improves tissue regeneration, and has a local analgesic effect.

Pharmacokinetics

Data on the pharmacokinetics of Polyminerol® are not available.

Indications

  • Initial and progressive stages of periodontopathy;
  • Gingivitis;
  • Periodontal disease;
  • Gingivostomatitis;
  • For the prevention of gum diseases.

The drug is most effective in gum diseases accompanied by bleeding.

ICD codes

ICD-10 code Indication
K05 Gingivitis and periodontal diseases
K12 Stomatitis and related lesions
ICD-11 code Indication
DA01.Z Diseases of the oral mucosa, unspecified
DA0B.Z Gingival diseases, unspecified
DA0C.Z Periodontal diseases, unspecified
DA0Z Diseases or disorders of the orofacial complex, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

The drug is intended for topical use.

Treatment of catarrhal, ulcerative, hypertrophic gingivitis, and the initial phase of treatment of periodontal disease should be carried out by a dentist. Treatment should begin with the removal of tartar, as well as the elimination of all possible causes of gum irritation. Before each therapy session with Polyminerol®, the interdental spaces and gum pockets should be cleaned.

Prevention of gum diseases is carried out by the patient himself by rinsing the mouth with a diluted solution (1:4) for 5 minutes 1-2 times/day.

For catarrhal gingivitis, it is recommended to rinse the mouth with a diluted solution of Polyminerol® (1 part of the drug to 4-5 parts of water) at least 3 times/day for 10 minutes. After using the drug, you should not rinse your mouth with water. If this therapy is ineffective, it is recommended to apply dressings with undiluted Polyminerol® mixed with fletcher (a paste for a temporary dressing): mix fletcher with Polyminerol® and knead to the consistency of a soft dough. The mixture of Polyminerol® and fletcher is applied to gauze strips, which are applied to the gums with the gauze facing outward. The dressing hardens after a few minutes and is kept for 2-3 hours to a day. The patient can remove the dressing himself.

For ulcerative and hypertrophic gingivitis, treatment begins with the application of dressings, with cotton swabs soaked in Polyminerol® placed in the interdental spaces, and loose cotton drains placed in the gum pockets. Dressings are applied every other day. Additionally, you should rinse your mouth daily with a diluted solution of Polyminerol®.

For periodontal disease in the initial phase, dressings with Polyminerol® are used in combination with drains in the interdental spaces and rinsing the mouth with a diluted solution of Polyminerol®.

For periodontal disease in the progressive stage in the presence of gum pockets, cotton drains soaked in the drug are deeply inserted into the bottom of the pocket using a probe; initially, they should be changed 2-3 times every 5 minutes, and a dressing is applied to the gum. Only drains or only dressings can be used, but their combination gives a faster effect. Rinsing the mouth should always accompany the use of dressings and drains.

The course of treatment consists of 10-15 dressings. Dressings are applied every other day, the last 4-5 procedures – 2 times a week. If the treatment consists only of drains, at the beginning of therapy they are done every day, and then after 20-30 days.

Adverse Reactions

With tight application of tampons, subfebrile temperature is possible, due to impaired outflow of purulent exudate, which disappears on its own after removal of the tampons.

Contraindications

  • Hypersensitivity to the components of the drug.

Use in Pregnancy and Lactation

The drug can be used during pregnancy and lactation (breastfeeding).

Special Precautions

During treatment, a soft toothbrush should be used and the oral cavity should be cleaned carefully. The use of Pomorin toothpaste and the intake of high-calorie and vitamin-rich food are recommended. Additionally, it is recommended to take vitamins A, B1, C, D, E. Active treatment of concomitant diseases is necessary, especially if they are associated with gum disease (diabetes mellitus, peptic ulcer, gastritis, neurasthenia).

If necessary, Polyminerol® can be used in combination with other drugs, for example, antibiotics, in the treatment of progressive forms of periodontal disease or in severe cases of ulcerative stomatitis.

The result of treatment will be more stable if the patient rinses the mouth with a diluted solution of Polyminerol® for a long period of time after the end of therapy. Rinsing is also indicated for prevention in case of predisposition to gum diseases.

Overdose

Cases of overdose with Polyminerol® have not been reported to date.

Drug Interactions

Drug interactions of Polyminerol® have not been established.

Storage Conditions

The drug should be stored at a temperature from 15°C (59°F) to 30°C (86°F).

Shelf Life

Shelf life – 3 years.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS